Cullinan Therapeutics, Inc. (CGEM)
10.14
-0.05
(-0.49%)
USD |
NASDAQ |
Nov 13, 11:33
Cullinan Therapeutics Net Income (Annual) : -219.88M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -219.88M |
| December 31, 2024 | -167.58M |
| December 31, 2023 | -155.10M |
| December 31, 2022 | 109.20M |
| Date | Value |
|---|---|
| December 31, 2021 | -67.48M |
| December 31, 2020 | -59.46M |
| December 31, 2019 | -21.65M |
| December 31, 2018 | -14.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Climb Bio, Inc. | -59.85M |
| MapLight Therapeutics, Inc. | -161.15M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |